BIO-Europe Spring® 2016: Seventure Partners targets the microbiome revolution

June 20, 2016
Eric de la Fortelle, venture partner with Seventure Partners in charge of investments in the Benelux, Scandinavia, Northern Switzerland and North America speaks to Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio, about the VC's new fund that focuses on the microbiome revolution. Seventure Partners closed the final round of its EUR 160 million Health for Life Capital vehicle, the world’s first investment fund aimed at health and nutrition, in December 2015. Seventure, a subsidiary of Natixis Global Asset Management, has four areas of focus in life sciences including biotechnology and pharmaceuticals, connected health and medtech, industrial biotechnology, and the microbiome comprising nutrition, foodtech and personalized medicine.
Previous Video
BIO-Europe Spring® 2016: Achelous Partners is built on knowing life sciences and finance sectors
BIO-Europe Spring® 2016: Achelous Partners is built on knowing life sciences and finance sectors

The European Representative of Achelous Partners, Jan Boesen, explains the investment bank's strategy and s...

Next Video
BIO-Europe Spring® 2016: Strategic unit at MD Anderson forges creative alliances
BIO-Europe Spring® 2016: Strategic unit at MD Anderson forges creative alliances

Shara Avis, business development specialist at MD Anderson Cancer Center—a world-renown research center—spe...